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Abstract 
 
This thesis aimed to evaluate the cardiac reserves capacity to be used to predict 
treatment effects, sub clinical heart disease and to evaluate β1-adrenoceptor (AR) 
gene polymorphism (Ser49Gly).  
Studies were performed in patients with dilated cardiomyopathy, in rats 
(young, healthy, diabetic and hypertensive), in mice (immunized against the 
β1AR) and in heart-transplanted patients. 
The cardiac reserve was assessed by low-dose dobutamine stress 
echocardiography. In both patient studies by dobutamine infusion until an 
increased baseline heart rate with ~20 bpm, in rats at doses of 10 μg/kg/min 
and 20 μg/kg/min dobutamine and in mice after an intraperitoneal injection of 
1 μg dobutamine/g of body weight. 
Both global and regional cardiac reserve can be used to predict treatment 
effect of metoprolol in dilated cardiomyopathy patients. However, only cardiac 
reserve in the basal segments of the heart was independently associated with 
recovery. In heart transplanted patients a gene-polymorphism in the β1AR in the 
graft affects cardiac reserve. Patients having the β1AR Gly49 variants had a lower 
resting heart rate, a better stress endurance and chronotropic reserve than 
patients homozygous for Ser49. They also had better diastolic function shown as 
better lusitropic capacity. Cardiac reserve can also be used to investigate sub 
clinical heart disease in β1AR immunized mice and to predict heart disease 
development in these animals. Furthermore, cardiac reserve decreases with age 
and is depressed both in hypertension and in diabetes rat model.  
We conclude that cardiac reserve can predict left ventricular recovery 
during beta-blocker treatment and that β1AR polymorphism affects cardiac 
reserve in humans. Cardiac reserve decreases with age and is impaired both in 
severe heart disease and during progression of myocardial dysfunction in rats. 
Furthermore, cardiac reserve can be used to predict cardiomyopathy 
development after β1AR immunization in mice.  
Svensk sammanfattning
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Svensk sammanfattning 
 
Hjärtats kardiella reserv är ett mått på skillnaden i dess pumpförmåga mellan vila 
och stress. Denna avhandling studerar möjligheten att använda den kardiella 
reserven för att prediktera subklinisk hjärtsjukdom och behandlingseffekt samt 
för att utvärdera den kliniska betydelsen av polymorfism (Ser49Gly) i genen för 
den β1-adrenerga receptorn (AR). 
Studierna utfördes på patienter med dilaterad kardiomyopati och 
hjärttransplanterade patienter samt i experimentella studier på råttor och möss. 
Den kardiella reserven studerades med lågdos dobutaminstress-ekokardiografi; på 
patienterna genom att öka vilopulsen med 20 slag/min, på råttor vid två doser 
dobutamin (10μg/kg/min; 20μg/kg/min) och på möss med en intraperitonal 
dobutamininjektion (1 μg/g kroppsvikt). 
Kardiell reserv kan användas för att prediktera behandlingseffekt av 
metoprolol (β1-selektiv receptorblockerare) hos patienter med dilaterad 
kardiomyopati. Den kardiella reserven i de basala delarna av hjärtat var oberoende 
knuten till förbättringen efter behandling. Hos de hjärttransplanterade 
patienterna sågs skillnader i kardiell reserv beroende på en gen-polymorfism i 
β1AR. Framför allt syntes skillnader i hjärtats pulsreserv och relaxationsförmåga 
(lusitrop) samt i patienternas fysiska uthållighet. Den kardiella reserven sjunker 
med ålder och är nedsatt vid högt blodtryck och vid diabetes hos råttor precis som 
hos människor. Den kardiella reserven kan användas för att studera subklinisk 
och klinisk hjärtsjukdomsutveckling hos β1AR immuniserade möss och prediktera 
hjärtsjukdomsutveckling hos dessa djur. 
Slutsatserna av denna avhandling är att den kardiella reserven, utvärderad 
med lågdos dobutaminstress-ekokardiografi, kan användas för att prediktera 
behandlingsresultat av β-blockerare samt att den är påverkad av en 
genpolymorfism i β1AR. Den kardiella reserven sjunker med åldern och kan 
användas för att utvärdera och prediktera klinisk och subklinisk hjärtsjukdom i 
experimentella studier. En nedsatt kardiell reserv kan vara det första tecknet på 
begynnande hjärtdysfunktion. 
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Abbreviations 
 
ANOVA Analysis of variance  
ATP  Adenosintriphospate  
Av  Atrial myocardial velocity 
cAMP           Cyclic adenosin monophosphate 
BalbC  The Bagg albino mice 
bpm  Beats per minutes 
β1AR  β1-adrenoceptor 
β1AR ECII the second extracellular loop of β1AR  
CV  Coefficient of variation 
DCM  Dilated cardiomyopathy 
DSE  Dobutamine stress echocardiography 
DTI   Doppler tissue imaging   
E  Early transmitral flow velocity 
EF  Ejection fraction 
ERNA Equilibrium radionuclide angiography 
Ev   Early myocardial velocity 
G-protein  Guanine nucleotide protein  
Gi-protein  Inhibitory G-protein 
Gs-protein  Stimulatory G-protein 
HR   Heart rate 
FS  Fractional shortening 
LV   Left ventricular 
LVEF  Left ventricular ejection fraction 
NYHA New York Heart Association 
OR  Odd ratio 
PKA  Protein kinase A 
SHR  Spontaneously hypertensive rats 
Sv  Systolic myocardial velocity 
Vcf c  Velocity of circumferential fiber shortening corrected for heart rate 
VTI  Velocity time integral 
WKY  Whistar Kyoto rats 
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Introduction 
 
The Heart 
The heart is unique compared to other organs in the body since it starts 
functioning before it is fully formed. After fertilization, the first indication of the 
development of a human heart is between day 16-19 and the heart starts to beat 
around the 22nd day. However, the circulation does not start until around the 
28th day, at this point the heart is approximately 4 mm in length. This usually 
happens before the woman realizes she is pregnant and when the embryo is too 
small to be visualized in detail by ultrasound.  
The heart beats about 100 000 times daily or about two and a half billion 
times over a 70 year lifetime. Heart disease is a major cause of death in the 
western world and about 43% of all deaths in Sweden during 2004 were caused 
by cardiovascular disease [Socialstyrelsen, 2007]. 
Left ventricular function 
Left ventricular (LV) function is traditionally divided into systole and diastole, 
describing ventricular emptying and filling. Systolic function of the heart depends 
on end-diastolic volume (preload) and on myocardial activation (inotropy). 
Systolic function is most commonly measured as left ventricular ejection fraction 
(LVEF). Diastolic function depends on a series of events. The phase of isovolumic 
myocardial relaxation with a rapid LV pressure fall due to relaxation and elastic 
recoil is followed by the filling phases. The rapid early filling phase is related to the 
rate of myocardial relaxation and depends on the pressure gradient between the 
atrium and the left ventricle. In the study by Chemla et al, they came to the 
conclusion that the relaxation in the heart depends mainly on preload and 
inactivation (lusitropy) [Chemla, 2000]. The myocardial wall motion velocities 
both in systole and in diastole can be measure with Doppler tissue imaging (DTI). 
Mitral annulus velocity determined by DTI is a relatively preload independent 
variable and is superior to conventional mitral Doppler indexes [Farias, 1999] and 
some authors claim that diastolic early myocardial velocity can be a reliable 
marker for LV diastolic function [Galiuto, 1998, Sohn, 1997]. 
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Cardiac reserve 
Cardiac reserve can be studied with different types of tests; exercise, pacing and by 
pharmacologic stress. In this thesis, the cardiac reserve has been studied by 
pharmacologic stress with dobutamine. Cardiac reserve refers to the heart's ability 
to adjust to the demands placed upon it. The traditional definition of cardiac 
reserve is the maximum percentage that the cardiac output can increase above the 
resting level. It is calculated as the cardiac output during stress minus cardiac 
output at rest. In the normal young adult the resting cardiac output is about 5-6 
L/min and the cardiac reserve is nearly 30 L/min. For example, running to catch 
a tram would cause an increase in oxygen demand, which must be balanced by 
increased blood circulation. This increase in cardiac output is achieved by an 
increase in either heart rate or stroke volume or both. In the weak or elderly 
person, the cardiac reserve may be as low as 5-6 L/min. In severe heart failure the 
cardiac reserve can be markedly diminished or totally abolished [Guyton, 1991].  
One of the components in cardiac reserve is stroke volume. Stroke volume 
is dependent on preload, afterload and contractility (inotropy). Where preload is 
the volume of blood in the ventricle at the end of diastole and afterload the 
resistance against which the ventricle must eject during systole. Dobutamine 
decreases preload and afterload [Leier, 1978] by decreasing pulmonary and 
systemic vascular resistance and thereby reduce the pulmonary capillary wedge 
pressure. Increased inflow causes the end diastolic volume to increase (increased 
myocardial fiber length). In response to this augmented inflow, the ventricles 
contract more forcefully resulting in an increased stroke volume. Changes in 
stroke volume can be accomplished by changes in ventricular inotropy 
(contractility), this ability to increase contractility decreases with development of 
heart failure. The LVEF is the fraction of the end-diastolic volume that is ejected 
with each beat (stroke volume divided by end-diastolic volume) and LVEF is the 
inotropic component of the cardiac reserve. Increasing inotropy leads to an 
increase in LVEF, while decreasing inotropy decreases LVEF. LVEF is therefore 
often used as a clinical index for evaluating the inotropic state of the heart during 
stress. 
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Heart rate and the heart rate reserve also referred to as chronotropic reserve 
are also components in cardiac reserve. It is generally acknowledged that fast 
resting heart rate is associated with increased cardiovascular mortality [Kannel, 
1987].  In both men and women, independent of age, all-cause and cardiovascular 
mortality increased progressively with higher resting heart rates [Kannel, 1987]. 
Furthermore, heart rate reserve has shown to be a predictor of mortality and 
morbidity. Cheng et al have shown in 27 459 healthy men that heart rate reserve 
during exercise test was inversely associated with cardiovascular mortality [Cheng, 
2002]. Especially low heart rate reserve in healthy young men (age 20-39) seemed 
to be associated with higher cardiovascular mortality. Savonen et al  showed the 
same phenomena in healthy middle-age men [Savonen, 2006].  
 
 
 
 
The chemical structure for dobutamine 
 
Dobutamine 
Dobutrex® (Eli Lilly Sweden AB, Stockholm) were used in all studies. 
Dobutamine is a synthetic catecholamine, with strong agonistic activity at the β1-
adrenoceptor and mild agonistic activity at the β2- and α1-adrenoceptors [Jewitt, 
1974, Ruffolo, 1987]. Dobutamine can be used to assess lusitropic, inotropic and 
chronotrophic reserve [Hees, 2006] and it is dose depending with a main increase 
in contractility and cardiac output at lower doses [De Wolf, 1999] and a dose-
related increase in heart rate. Since dobutamine does not act on dopamine 
receptors to induce the release of norepinephrine (an α1- agonist), dobutamine is 
less prone to induce hypertension than dopamine. Dobutamine acts by increasing 
synthesis of cyclic adenosin monophosphate (cAMP) and is thereby dependent of 
both the adrenoceptors as well as of the G-protein (guanine nucleotide-binding 
protein) - adenylate cyclase - cascade.    
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Dobutamine stress echocardiography  
Dobutamine stress echocardiography (DSE) is commonly used as a pharmacologic 
stress to determine the presence of significant coronary artery disease and low-
dose DSE is a well-established method to investigate the cardiac reserve in 
humans with non-coronary heart disease [Kitaoka, 1999, Marwick, 2000, Naqvi, 
1999, Paelinck, 1999, Scrutinio, 2000]. As previously shown by Kyriakides et al the 
cardiac reserve decreases with age [Kyriakides, 1986] and is also decreased in heart 
disease both of ischemic and non-ischemic etiology [Vigna, 1996]. DSE has been 
used in different studies to predict survival and clinical outcome in patients with 
cardiomyopathy [Paraskevaidis, 2001, Scrutinio, 2000]. Furthermore, studies have 
demonstrated that LV global contractile reserve can predict improvement in 
LVEF after beta-blocker treatment (carvedilol, busindolol), in ischemic as well as 
non-ischemic cardiomyopathy patients [Eichhorn, 2003, Jourdain, 2002, Seghatol, 
2004]. Cardiac reserve has shown to provide incremental prognostic information 
for the prediction of cardiac events in patients with right bundle branch block 
[Biagini, 2004]. In contrast, assessment of cardiac reserve does not give additional 
information for the early detection of cardiomyopathy induced by cytostatic 
treatment [Bountioukos, 2003]. 
High dose dobutamine stress is a surrogate for maximal exercise test but 
they are not interchangeable. High dose dobutamine test is frequently used to 
evaluate coronary artery disease and for determining prognosis in these patients 
[Armstrong, 2005, Rambaldi, 2005, Vigna, 1996]. During high dose dobutamine the 
contractility is substantially higher and afterload is lower than during exercise test. 
However, cardiac output is higher during physiological exercise due to higher 
heart rate and preload which leads to a higher cardiac reserve during maximal 
exercise test compared to stress test with high dose dobutamine [Cnota, 2003].  
  The technology of echocardiography is rapidly improving making it 
possible to perform more advanced studies on small animals with good precision 
and accuracy and therefore DSE has been widely used in several animal models. 
In both rats and mice, DSE has mainly been used to study ischemia and 
remodelling after myocardial infarctions [Cove, 1995, Dawson, 2005, Fiordaliso, 
2005, Iwanaga, 2004, Salto-Tellez, 2004]. Studies on mice are now getting more 
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and more attention due to the unlimited resources of different gene manipulated 
mice (Knock-Out and Knock-In), elucidating differences in heart diseases and 
disease development. 
Coronary flow reserve 
When exploring cardiac reserve, investigations of coronary flow reserve might be 
of interest. Studies have shown that coronary flow reserve is reduced in several 
diseases affecting the heart i.e. dilated and hypertrophic cardiomyopathy, 
coronary artery disease, hypertension and diabetes mellitus. Coronary flow reserve 
is considerably reduced even when the systolic function appears normal or only 
slightly decreased in patients with heart failure [Neglia, 1995]. Neglia et al also 
showed that myocardial blood flow at rest and during pacing correlated inversely 
with LV end-diastolic pressure and did not correlate with LVEF. Teragaki et al  
among others suggests that coronary flow reserve in patients with dilated 
cardiomyopathy correlates better with diastolic than systolic parameters[Teragaki, 
2003]. However, detecting severely decreased coronary flow is a predictor of poor 
prognosis in patients with idiopathic LV dysfunction [Neglia, 2002]. 
 
Adrenoceptors 
The adrenoceptors of most interest during DSE are β1-, β2- and α1-adrenoceptors, 
since these receptors mainly regulate cardiac function. Ahlquist classified the 
adrenoceptor in 1948 into α (excitatory) and β (inhibitory) for their function in 
blood vessels [Ahlquist, 1948]. The β-adrenoceptor consists of three intra- and 
three extra-cellular loops. The β-adrenoceptor signaling pathway plays an 
important role in regulating the contractility and heart rate, Figure 1. Both β1- and 
β2-receptors couples to Gs-protein (stimulatory G-protein) to activate adenylyl 
cyclase that dephosphorylates adenosintriphospate (ATP) to form cAMP and 
stimulation of this receptor subtype increases the synthesis of cAMP. Increased 
cAMP activates protein kinase A (PKA), which through phosphorylation of 
phospholamban and calcium channels increases myocardial contractility. The 
phospholamban is a regulatory phosphoprotein which modulates the active 
transport of Ca2+ into the lumen of the sarcoplasmic reticulum. 
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Cardiac α1-adrenoceptors couple also via G-protein [Bristow, 1988] but 
mediate only a weak positive inotropic effect, thus the density of the α1-
adrenoceptor is only 10-15% of the β-adrenoceptor in the human heart. However, 
the α1-adrenoceptors in rat hearts, but not in mice have a five time higher density 
than in the human heart [Steinfath, 1992]. This could explain why rats generally 
have a greater increase in fraction shortening during dobutamine stimulation 
compared to that of humans and mice.  
In the failing and the ageing heart the α-adrenoceptor function is 
unchanged or only slightly decreased [Bristow, 1988, Brodde, 2004]. Whereas, the 
decreased β-adrenoceptor function both in failing and in ageing heart results in a 
reduction in cardiac reserve. The β-adrenoceptors downregulation with age 
appears already at a very young age (in 5 to 13 week old rats) in rats [Castellano, 
1993] considering that the breeding age for Whistar Kyoto rats is 10-12 weeks.  
Figure 1. Signaling pathway of the β-adrenoceptor.  
G, G-protein; PKA, Protein kinase A; GRK2, G-protein-coupled receptor kinase 2; PLB, 
phospholamban; SERCA 2a, sarcoplasmic reticulum calcium ATPase; RyR2,Ryanodine 
receptor. Adapted from Lisa Buvalls thesis 2006. 
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Polymorphisms of the β1-adrenoceptor 
The β1-adrenoceptor is encoded by an intron-less gene located on chromosome 
10. There are at least two known polymorphisms in the β1-adrenoceptor. The first 
polymorphism is located at nucleotide position 145 (Adenin→Guanin), resulting 
in an amino acid substitution of serine by glycine at codon 49, Ser49Gly 
[Borjesson, 2000]. The second polymorphism is located at nucleotide position 1165 
(Guanin→Cytosin), resulting in an amino acid substitution of arginine by glycine 
at codon 389, Arg389Gly [Tesson, 1999], see Figure 2. Neither of the 
polymorphisms in the β1-adrenoceptor can predict dilated cardiomyopathy 
[Magnusson, 2005] but dilated cardiomyopathy patients with the Gly49 variants 
had a improved long-term survival [Borjesson, 2000] and this polymorphism is also 
associated with resting heart rate. An additive model was presented, patients 
homozygous for Ser49 (74%) had the highest resting heart rate, patients 
homozygous for Gly49 (2.5%) had the lowest resting heart rate, and patients 
heterozygous for Ser49Gly (23.5%) were in between [Ranade, 2002]. 
 
 
 
 
Figure 2.  Human β1-adrenergic receptor polymorphisms 
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Cardiomyopathy 
The name cardiomyopathy comes from cardio = heart, myo = muscle and pathy = 
disease. In patients with cardiomyopathy, desensitization of the β-receptor 
pathway is observed due to the sustained increase in catecholamine stimulation.  
Catecholamine’s induce positive inotropic and chronotrophic response in the 
heart through the β-adrenoceptor. This sustained catecholamine stimulation 
results in a downregulation of the β-adrenoceptor density.  In normal human 
myocardium the β1: β2-adrenoceptor ratio is approximately 75:25% and in rodents 
about the same. In failing myocardium, the percentage of β1-adrenoceptors is 
reduced to about 60% and the β2-adrenoceptors is proportionally increased to 
40% [Bristow, 1986, Brodde, 2006].  
The α1-adrenoceptor in the human myocardium is of relatively low density 
and the density is unchanged in the failing human heart [Bristow, 1988]. 
Idiopathic cardiomyopathy 
Idiopathic dilated cardiomyopathy is a heart disease of unknown origin and it is 
characterized by impaired systolic function and dilatation of one or both 
ventricles. The incidence is 5-8 cases per 100 000 per year. Idiopathic dilated 
cardiomyopathy is associated with high morbidity and poor prognosis and is the 
second most common reason for heart transplantation in Sweden.  
About 30% of the idiopathic dilated cardiomyopathy patients have shown 
to have auto-antibodies against the β1-adrenoceptor. The most immunogenic 
target on the β1-adrenoceptor has been shown to be the second extracellular loop 
[Magnusson, 1994] and immunization with this part of the receptor has shown to 
induce dilated cardiomyopathy in rabbit [Matsui, 1999] and rat [Jahns, 2004].  
Ischemic cardiomyopathy 
Ischemic heart disease is caused by arteriosclerosis in the coronary arteries which 
lead to imbalance between the myocardial blood flow and the metabolic demand 
of the myocardium. Ischemic cardiomyopathy is the most common type of 
cardiomyopathy, 50-75% of all heart failure is due to ischemia.  
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Heart transplantation 
When the heart is transplanted it loses both its sympathetic and parasympathetic 
innervations, thus the transplanted denerved heart displays an exaggerated 
chronotropic response to exogenous catecholamines, probably due to the loss of 
the parasympathetic vagal tone [Gerber, 2001]. Consequently, they also display a 
higher resting heart rate. The total β-adrenoceptor density is unaltered in 
transplanted patients but some studies have shown that transplanted human heart 
exhibits an increase in the β2–adrenoceptor density over time. With increasing 
time after transplantation Steinfath et al found that the β1: β2-adrenoceptor ratio 
was altered, with a decrease in β1- and an increase in β2-adrenoceptor densities 
from about 80:20 to 60:40 which is similar to that in the failing heart [Steinfath, 
1992].  
The intraventricular septum has an enhanced sympathetic innervation 
[Poston, 2004] and consequently septum is in greater jeopardy of damage during 
the autonomic cascade following brain death [Novitzky, 1986]. Further, this could 
be the reason that septum is especially liable to future injuries. Septal hypokinesis 
is the most common wall motion abnormality seen in donor hearts [Poston, 2004]. 
Compared with healthy subjects, patients with heart transplants have higher 
resting heart rate but reduced chronotrophic reserve to endogenous sympathetic 
stimulation, causing a reduction of maximal exercise capacity [Ferretti, 2002, 
Hidalgo, 1989, Mandak, 1995]. Some reinnervation of the transplanted heart 
(anteriort) has been shown to occur with time after transplantation. With no 
reinnervation seen at one year and about 20-25% reinnervation after five year 
[Bengel, 2001, Uberfuhr, 2000]. 
 
Hypertension 
Hypertension results in β-adrenoceptor downregulation and Gi-protein 
(inhibitory G-protein) alterations, similarly to that in heart failure [Bohm, 1995, 
Castellano, 1997] and it is a well known cause of heart disease. Furthermore, in 
spontaneously hypertensive rats a relative decrease of β1-adrenoceptor and an 
increase in β2-adrenoceptor were observed [Girouard, 2003]. The risk of developing 
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heart failure in hypertensive compared with normotensive subjects has been 
shown to be 2-fold in men and 3-fold in women [Levy, 1996].  
Diabetes  
There is a high frequency of heart failure accompanied by an increased mortality 
risk for patients with diabetes. Diabetic subjects have shown to have elevated levels 
of Gi-protein [Richardson, 2004] and an increased Gi-protein signalling is 
associated with heart failure [Neumann, 1988]. One experimental models of non-
insulin depending diabetes is to inject a low dose of Streptozotocin after high fat 
diet [Zhang, 2003]. Streptozotocin-induced diabetic swine have an increase in the 
Gi:Gs-protein ratio [Roth, D. A., 1995] so although the β-adrenoceptor density is 
maintained, adenylyl cyclase is depressed in diabetics resulting in a depressed LV 
function as well as a depressed catecholamine responsiveness and cardiac 
performance. 
Aims
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Aims 
 
To study with low-dose DSE: 
 
 
♥ if cardiac reserve could be used to predict, global and/or regional 
improvement after metoprolol treatment.  
 
♥ cardiac reserve during concealed and progressing myocardial 
dysfunction and during ageing in rats. 
 
♥ if cardiac reserve could predict future development of dilated 
cardiomyopathy in immunized (β1AR ECII) mice. 
 
♥ cardiac reserve in heart transplanted patients and if the β1-
adrenoceptor genotype has significance for the cardiac reserve. 
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Material and methods 
 
Ethic approval 
The human studies were carried out in accordance to the Declaration of Helsinki, 
with approval of the Ethic Committee at the Medical Faculty, Göteborg 
University, and informed written consent was obtained from all patients. 
In all animal experiments the principle of laboratory animal care was 
followed and the studies have been carried out with approval of the regional 
Animal Ethic Committee at Göteborg University. 
 
Patients 
Study I.  
Twenty-nine patients, clinically stable, in NYHA class II-III and LVEF <50%, 
measured by equilibrium radionuclide angiography (ERNA), were randomised to 
metoprolol or placebo. During the first 6 months (the double-blind phase) 3 
patients were withdrawn (ventricular fibrillation, skin reaction and patient 
request) and during open treatment 2 patients were withdrawn (increased heart 
failure and patient request) and 2 patients were missed due to technical problems. 
The remaining 22 patients (mean age 58 years, 5 females) were evaluated in this 
study and data from before and after 6 month treatment are shown.  There were 
16 patients with non-ischemic dilated cardiomyopathy and 6 patients with 
ischemic cardiomyopathy (post coronary bypass, 1; one-vessel disease, 2; two-vessel 
disease, 2; three-vessel disease, 1). The patients with ischemic cardiomyopathy 
were not suffering from angina pectoris, and had no sign of exercise-induced ST-
segment depression.  
Study IV.  
The study was performed in 20 patients (mean age 48 years, 5 females). Maximal 
bicycle exercise test (ramp protocol) and echocardiography at rest and during low-
dose DSE were performed 17 months (range 12 - 48 months) after heart 
transplantation. In 15 patients a central hemodynamic investigations was 
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performed within one week of the echocardiographic investigation. The origins of 
heart failure were; dilated cardiomyopathy in 12 patients, ischemic 
cardiomyopathy in 7 patients and hypertropic cardiomyopathy in one patient. 
Exclusion criteria were coronary artery stenosis as confirmed by coronary 
angiography, other serious diseases potentially affecting the cardiac reserve and 
beta-blocker treatment. They were all on immunosuppressant treatment (9 
tacrolimus, 11 cyclosporine).   
The β1-adrenoceptor polymorphism was determined by the allelic 
discrimination analysis and patients were divided into two groups: either 
homozygous for Ser49 (n=15) or with Gly49 in one or both alleles (Gly49; n=5).  
 
Rats 
Study II  
Forty-eight DSE examinations were performed in a total of 40 male rats (Charles 
River lab, Sulzfeld, Germany). Ten Whistar Kyoto (WKY) rats, age 16 weeks 
(WKY16); 10 WKY rats, age 26 weeks (WKY26); 10 WKY rats (26 weeks) with 
diabetes (WKY+D); and 10 spontaneously hypertensive (SHR) rats (26 weeks). For 
the study of repeatability, and inter- and intraobserver variability, 16 week old 
WKY rats were used (n=8). 
The animals were acclimatized for at least 1 week and were housed under 
standard conditions. The 10 WKY rats, in which diabetes was induced, were first 
fed with a high saturated fat diet (MP Biomedicals Inc. Sweden, 4.39 kcal/g) for 8 
weeks, followed by one intravenously (i.v) injection of 20 mg/kg streptozotocin 
(STZ) resulting in a blood glucose level of 7.6 ± 0.9 mmol/L and became non-
insulin depending animals.   
All animals were weighed and lightly anesthetized with 1.6-2.7% isofluran 
(Abbot Scandinavia AB, Solna) [Kober, 2004, Roth, D. M., 2002] through a nose 
cone. The thorax was shaved, and the animal was placed in a slight left decubitus 
position on an electrical heating pad to maintain normothermia during the 
examination. A neoflon i.v cannula ∅ 0.7 mm was placed in the tail vein for the 
intravenous administration of dobutamine. 
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SHR originate from Okamoto in 1963 from outbred Wistar Kyoto rats. 
Bred from a male with mild hypertension, mated with a female with high blood 
pressure. Brother x sister mating with continued selection for high blood 
pressure. (Albino) 
WKY originate from National Institutes of Health in 1971 from outbred 
Wistar stock from Kyoto School of Medicine. Inbred as a normotensive control 
strain for SHR. (Albino) 
(An inbred strain is one that has been maintained by sibling (sister x brother) 
mating for 20 or more consecutive generations.) 
 
Mice  
Study III 
Thirty-seven male BalbC mice (AgriSera, Sweden) were immunized with a 
synthetic peptide (H26R) corresponding to the human and mouse second 
extracellular loop on the β1-adrenoceptor (β1AR ECII). When the mice were 7 
weeks old the immunization started by subcutaneous injection, of 0.2 mg H26R 
peptide, dissolved in 0.1M Na2CO3/1% β-mercaptoethanol and emulsified in 
Freund ’s adjuvant, with a four week interval, for 14 or 25 weeks. Another 33 
male BalbC mice were used as controls receiving vehicle in the same manner. Rest 
and DSE where performed in 12 β1AR ECII  immunized (14 week old), 12 control 
(14 week old) and only rest echocardiography in 23 β1AR ECII immunized (25 
week old) and 18 control mice (25 week old).  
Thorax was shaved and the animal was placed in a slight left decubitus 
position on an electrical heating pad (38ºC) to maintain normothermia. All 
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animals were anesthetized with 1.1% isofluran (Abbot Scandinavia AB, Solna, 
Sweden) via a nose cone during the echocardiographic examination. 
 
  BalbC mice originate from Dr MacDowell at the Carnegie Institution of 
Washington in Cold Spring Harbor, New York, who started inbreeding in 1920 
with stock obtained from Dr Bagg at Memorial Hospital in New York who 
obtained albinos from a mouse dealer in Ohio in 1913. 
 
Methods 
Echocardiography 
Study I. The echocardiography investigations were performed on an Acuson XP 
128 (Mountain View, CA, USA) and were recorded on VHS videotape. The 
evaluations were performed off-line on an Echo-Pac (Vingmed, Horten, Norway) 
system by one investigator who was blinded to patient data and time of 
investigation. 
Studies II - III were performed on a HDI 5000 ultrasound system (ATL, 
Philip Medical System, Best). Using a high frequency 12-MHz phased array 
transducer (P12-5, Philip Medical System, Best) in the rat study, and a high 
frequency 15-MHz linear transducer (CL 15-7, Philip Medical System, Best) in the 
mice study. All animal data were evaluated off-line on an Echo-Pac (Vingmed, 
Horten, Norway) system by one investigator blinded to the animal’s identity. 
In study IV, an Acuson Sequoia 512 with a 3v2c phased array cardiac 
transducer (Mountain View, CA, USA) was used and the examinations were 
evaluated one-line on the Sequoia by one investigator blinded to patient β-
receptor genotype. 
All echocardiographic investigations were performed according to 
recommendations of the American Society of Echocardiography [Henry, 1980, 
Sahn, 1978, Schiller, 1991]. 
Dobutamine stress echocardiography  
In study I on dilated cardiomyopathy patients, dobutamine was infused i.v and the 
initial dose was 5 μg/kg/min for 5 minutes, increased with 5 μg/kg/min every 5 
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minute [Weissman, 1995] until the desired heart rate was achieved. The aim was to 
increase baseline heart rate by 20 bpm so that cardiac reserve could be studied 
without inducing myocardial ischemia.  
 Study II on rats, dobutamine was infused i.v via a neoflon in the tail vein at 
doses of 10 μg/kg/min and 20 μg/kg/min. Cardiac reserve was studied on each 
dose after at least 5 minutes dobutamine infusion.  
 In study III on mice, 1 μg dobutamine per gram of body weight was given 
intraperitoneally (i.p) and cardiac reserve was studied after 5 and 10 minutes. 
 Study IV on transplanted patients, an initial dose of 2.5 μg/kg/min was 
infused i.v with incrementing doses of 2.5 μg/kg/min until 7.5 μg/kg/min or 
until desired heart rate was achieved (same as in study I). Cardiac reserve was 
studied at each dose. 
Doppler tissue imaging and estimated pulmonary capillary wedge pressure 
In study IV, myocardial velocities were measured by pulsed-wave Doppler tissue 
imaging (DTI) placing a 2.0 mm pulsed-wave sample volume at the junction of the 
mitral annulus in 4 basal sites: septum, lateral, anterior and inferior wall. Systolic 
velocities (Sv) together with early (Ev) and atrial (Av) diastolic velocities were 
measured from at least 3 cardiac cycles and averaged.  
We compared the measured pulmonary capillary wedge pressure during 
heart catheterization with the estimated pulmonary capillary wedge pressure with 
Doppler tissue imaging, as proposed by Sundereswaran et al  1.46 * (early 
transmitral flow velocity (E)/ Ev lateral site) + 2.6 = estimated mean pulmonary 
capillary wedge pressure, to investigate the effect of dobutamine in transplanted 
patient [Sundereswaran, 1998].  
Validity and repeatability, intra- and intervariability 
Intra- and interobserver error (s) was calculated according to the formula 
s=SD/√2. The coefficient of variation (CV) describes the difference as a 
percentage of the pooled mean values ( ) and was calculated according to the 
formula CV(%) = s * 100/  . 
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In study I we found a good correlation (r=0.77, p<0.001) and acceptable 
agreement according to Bland-Altman between LVEF measured by ERNA and 
echocardiography, see Figure 3. In this study intraobserver variability for LVEF 
was shown and the coefficient of variation was 4.7% in these patients with a 
correlation of r=0.96, p<0.001, see Figure 4.  
Figure 3. Correlation and agreement of left ventricular ejection fraction between 
radionuclear angiography (ERNA) and echocardiography. 
Figure 4. Intraobserver variation in left ventricular ejection fraction. 
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Data from the double-blind phase from the placebo group is not presented 
in study I. However, in the placebo group (n=9) the LVEF were not altered during 
the 6 month placebo period, rest echocardiography (26 ± 6% vs. 26 ± 11%, ns) 
and DSE (32 ± 9% vs. 37 ± 9%, ns). 
In study II, we could show excellent intra- and interobserver variability, as 
well as repeatability data in rats (Table 1). 
 
Table 1. Echocardiography data from rats 
 Measurement Repeatability 
16w vs.17w 
Intra 
variability 
Inter  
variability 
  Difference CV (%) Difference CV (%) Difference CV (%) 
R
E
ST
 
HR (bpm) 3 ± 21 3.7 3 ± 15 1.4 4 ± 15 1.4 
PA VTI (cm2) -0.08 ± 0.66 7.1 -0.07 ± 0.91 4.8 0.03 ± 0.90 4.8 
LVEDd (mm) -0.09 ± 0.16 1.6 0.00 ± 0.01 0.7 0.01 ± 0.01 0.5 
LVESd (mm) 0.00 ± 0.14 3.4 0.01 ± 0.03 3.6 0.01 ± 0.04 5.1 
LVPWd (mm) 0.004 ± 0.013 6.9 -0.004 ± 0.016 4.1 0.005 ± 0.013 3.3 
FS (%) -0.6 ± 2.6 3.1 -0.4 ± 4.5 2.7 -1.2 ± 5.9 3.6 
Vcf c (circ/s) 0.13 ± 0.28 5.8 –0.17 ± 0.38 4.0 –0.18 ± 0.49 5.2 
10
 μ
g/
kg
/m
in
 
 
HR (bpm) 13 ± 47 8.7 1 ± 5 0.4 1 ± 8 0.8 
PA VTI (cm2) 0.22 ± 0.57 5.9 0.10 ± 0.39 2.1 0.01 ± 0.35 1.8 
LVEDd (mm) -0.10 ± 0.39 4.1 0.00 ± 0.03 1.7 0.01 ± 0.03 1.7 
LVESd (mm) -0.04 ± 0.23 7.0 -0.01 ± 0.02 2.5 -0.01 ± 0.03 3.8 
FS (%) -0.14 ± 1.98 2.1 0.85 ± 3.05 1.7 0.90 ± 4.31 2.3 
Vcf c (circ/s) -0.38 ± 0.32 5.7 -0.05 ± 0.35 3.3 -0.02 ± 0.33 3.1 
20
 μ
g/
kg
/m
in
 
 
HR (bpm) 3 ± 29 4.9 -0 ± 9 0.8 -1 ± 10 0.8 
PA VTI (cm2) -0.18 ± 1.14 10.4 0.03 ± 0.55 2.5 -0.15 ± 0.67 3.0 
LVEDd (mm) -0.08 ± 0.17 1.8 -0.00 ± 0.02 1.1 0.01 ± 0.02 1.2 
LVESd (mm) -0.09 ± 0.40 14.3 0.00 ± 0.02 15.8 -0.00 ± 0.02 12.0 
FS (%) 1.4 ± 1.3 1.0 -0.48 ± 3.10 1.2 0.28 ± 2.32 0.9 
Vcf c (circ/s) 0.37 ± 0.59 7.0 -0.06 ± 0.79 4.9 -0.10 ± 0.54 3.3 
Heart rate(HR), Pulmonary artery velocity time integral (PA VTI), Stroke volume (SV), Left 
ventricle end diastolic diameter (LVEDd), Left ventricle end systolic diameter (LVESd), Left 
ventricle posterior wall dimension (LVPWd), Fractional shortening (FS) and Velocity of the 
circumferential fiber shortening (Vcf c). Data is shown as differences ± SD. 
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The repeatability data for heart failure patients, done in our laboratory are 
shown in Table 2, together with interobserver variability in a group of healthy 
controls, also shown in Table 2. 
 
Table 2. Repeatability data from heart failure patients and variability data from 
healthy controls 
 Repeatability in heart failure patients 
mean days 35.5 ± 13.7  
n=10 
 
Interobserver variability  
in controls 
n=6 
(MST vs BGS) 
Measurement Diffrence CV% Diffrence CV% 
LVEF (%) 0.44 ± 2.70 4.22 1.34 ± 1.30 1.47 
LVEDV (ml) 2.22 ± 16.51 8.30 2.08 ± 8.35 5.14 
LVESV (ml) 0.44 ± 11.31 10.20 2.42 ± 3.45 5.62 
E (m/sec) 0.00 ± 0.09 10.52 0.00 ± 0.03 2.60 
A (m/sec) -0.03 ± 0.10 12.89 -0.01 ± 0.02 3.77 
VTI (cm2) -0.53 ± 2.64 10.14 0.00 ± 0.01 2.15 
Sv (cm/sec) 0.47 ± 1.07 9.50 0.18 ± 0.20 1.27 
Ev (cm/sec) 0.24 ± 1.08 8.28 0.00 ± 0.39 1.56 
Av (cm/sec) 0.61 ± 2.03 14.66 0.24 ± 0.30 2.57 
Left ventricular ejection fraction (LVEF), Left ventricle end diastolic volume (LVEDV), Left 
ventricle end systolic volume (LVESV), Early filling velocity (E), Late filling velocity (A), 
Velocity time integral (VTI),  Doppler tissue imagine: systolic (Sv) myocardial velocity, early (Ev) 
and atrial (Av)diastolic myocardial velocity. Margareta Scharin Täng (MST), Bente Grüner 
Sveälv (BGS) Data is shown as differences ± SD. 
 
Measurement precision 
In the animal studies we have used a Phillips ATL HDI 5000 which has an axial 
resolution of approximately 0.05 mm (which means that two echoes closer than 
0.05 mm cannot be separated). One image point (pixel) is approximately 0.05 
mm. In each single measurement point, the maximal deviation from true value 
will be maximum half a pixel, 0.025 mm. However, measuring a distance between 
two echoes, a pair of points is marked. The maximal deviation from the true 
distance will therefore be 0.05 mm, and varies from the true value with a SD of 
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0.02 mm [Schmidt, 1999]. Phillips ATL HDI 5000 offers a good temporal 
resolution in M-mode with a frame rate of about 800 frames/s. 
 
Statistic 
Data are presented as mean (± SD) in tables and text and as mean (± SEM) in 
figurers. A p-value <0.05 was considered statistically significant. Data were 
analyzed using SPSS 9-11 for Windows (Chicago, Ill, USA) and GrafPad 4 (San 
Diego,Ca,USA). 
In the human studies (I+IV) the differences between groups were assessed 
by Mann-Whitney U test and in study I we also used Wilcoxon signed rank test, 
ANOVA (analysis of variance), Fischer’s exact test and a multivariate logistic 
regression.  
 In the animal studies difference between groups and within groups was 
assessed by paired t-test and Student’s t-test, or Mann-Whitney U test as 
appropriate. We have also used both one-way and two-way ANOVA. 
For assessing correlation and agreement between two methods or 
repeatability (Studies I,II and IV), we used the approach suggested by Bland and 
Altman [Bland, 1986] and Spearman´s rho for correlation in study I+IV. 
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Results 
 
Study I 
LVEF increased significantly after 6 months treatment with metoprolol both at 
rest (29 ± 10% vs. 34 ± 12%, p<.05) and during DSE (33 ±11% vs. 42 ± 12%, 
p<.01). Cardiac reserve in the basal segments predicted improvement in global LV 
function best with sensitivity 89%, specificity 77%, and accuracy 82%, 
p<0.01(Figure 5). Global and basal cardiac reserve was univariately predictive of 
LVEF improvement (p<0.02), only basal cardiac reserve was independently 
associated with recovery OR 1.07 [95% CI, 1.01–1.21], p=0.02 in a multivariate 
logistic regression analysis. Further, significant differences were observed in 
regional cardiac reserve between poor, moderate and good responders to 
metoprolol and the cardiac reserve of basal segments (Figure 6) were significantly 
better in good responders and negative in the poor responders. 
Figure 5. Different predictive models were compared by constructing receiver operating 
characteristic–area under curve (AUC). The capability to detect an improvement in global 
LVEF by >5% during 6 months treatment with metoprolol is displayed. Assessment of cardiac 
reserve in basal segments (AUC 0.87) and global LV function (AUC 0.82) were best predictive 
of future improvement in LV function, the mid and apical segments displayed poorer values 
(AUC 0.54 and 0.52, respectively)  
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Figure 6.  Cardiac reserve in different sections of the left ventricle at baseline, related to the 
response in global LVEF during long-term treatment. There was a significant difference 
among the three groups (poor, moderate and good responders) in contractile reserve of the 
basal segment (p<0.05), and in the apical segments (p<0.01). Data are given as fractional 
improvement of contractile reserve i.e. changes in amplitude/mean amplitude at baseline * 100. 
Apical segments striped, mid segments white, and basal segments black. 
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Study II 
There were no differences in cardiac function at rest between younger and older 
WKY rats. At rest the hypertensive rats had lower velocity of circumferential fiber 
shortening (Vcf c), compared to healthy age-matched controls (WKY26). All 
functional variables were impaired in diabetic rats, compared to WKY26.  
Younger rats had significantly larger cardiac reserve during the second dose 
of DSE. Hypertensive rats showed decreased cardiac reserve and diabetic rats did 
not improve their cardiac reserve as much as age-matched WKY during the DSE 
(Figure 7 and 8). 
 
 
 
 
 
 
Figure 7 and 8. Effect of dobutamine dose and disease (A) and age (B) on fraction shortening 
(7) and velocity of circumferential fiber shortening corrected for heart rate (8).  
FS, Fractional shortening; SHR, spontaneously hypertensive rats; Vcf c, velocity of the 
circumferential fiber shortening corrected for HR; WKY16, Whistar Kyoto rats aged 16 weeks; 
WKY26, Whistar Kyoto rats aged 26 weeks; WKY+D, Whistar Kyoto rats with non-insulin 
depending diabetes.  Values are mean ± SEM 
7A 
7B 8B 
8A 
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The repeatability study showed good agreement shown here with fractional 
shortening measurement (Figure 9) with good coefficients of variation at rest 
(<4%) and at both doses of dobutamine (<3%) in the WKY16 rats studied twice.  
 
 
 
 
 
Figure 9. Repeatability of fractional shortening (FS) during DSE in rats at 16 and 17 weeks. 
Bland-Altman plots at rest (A) and during 10 μg/kg/min (B) and 20 μg/kg/min (C) 
dobutamine. Correlation of fractional shortening at 16 weeks vs 17 weeks (D).  
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Study III 
When studying the mice at 14 weeks, no significant differences were seen between 
β1AR ECII immunized mice and controls at rest. During DSE a significantly lower 
cardiac reserve was observed in the β1AR ECII immunized mice at both time 
points studied (Figure 10). 25 weeks of immunization resulted in left ventricular 
dysfunction with a dilatation of the left ventricle, a decrease in fractional 
shortening and a thinner left ventricular posterior wall at rest in the β1AR ECII 
immunized mice. The immunized animals also displayed increased levels of B-type 
natriuretic peptide (1.18 ± 0.05 vs. 0.98 ± 0.08, p<0.05) and G-protein-coupled 
receptor kinase 2 (0.93 ± 0.03 vs. 0.80 ± 0.03, p<0.05) in the heart tissue after 25 
weeks of immunization. 
 
 
 
 
Figure 10. Cardiac reserve after 14 weeks of immunization 
Left ventricular end systolic diameter (A).  Left ventricular end diastolic diameter (B).  
Fractional shortening (C). Velocity of circumferential fiber shortening(D). 
β1AR ECII immunized mice vs. controls at baseline (0) and 5 and 10 min after dobutamine 
injection. Data is given as mean ± SEM, ***p< 0.001 between groups.  
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Study IV 
Heart transplanted patients with grafts having the β1-adrenoceptor Gly49 variants 
(n=5) had a lower resting heart rate (82 ± 7 vs. 90 ± 7 bpm, p=0.04), a better stress 
endurance and a trend towards a better chronotropic reserve than patients 
homozygous for Ser49 (n=15), see Figure 11. They also have better diastolic 
function shown as better lusitropic capacity in septum, see Table 3. There were no 
significant differences in LVEF between the two groups see Figure 12, with the 
exception of a decrease in cardiac reserve (∆LVEF) at the lowest dose of 
dobutamine in the patients with the Gly49 variants (-4.4 ± 1.5 vs. 2.2 ± 5.8, 
p<0.05).  
 
 
 
Figure 11. Stress bicycle endurance and chronotrophic reserve 
Gly49, with Gly49 in one ore both alleles; Ser49, homozygous for Ser49  
Values are mean ± SEM.* p<0.05, # p<0.06 
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Table 3. Pulsed wave Doppler tissue velocity at rest and during low-dose 
dobutamine infusion. 
 
Gly49, with at least one Gly allele; Ser49, homozygous for Ser49 
bpm, beats per minute; #, Dobutamine was infused at 2.5 μg/kg/min and at higher doses to 
induce an increase in heart rate of 20 bpm (∆HR 20 bpm); Ev, early diastolic myocardial 
velocity; Sv, systolic myocardial velocity. Values are mean ± SD 
 
 
Figure 12.  LVEF measured at rest and during low doses of dobutamine.  
Gly49, with Gly49 in one or both alleles; Ser49, homozygous for Ser49; Dobutamine was infused 
at 2.5 μg/kg/min and at higher doses to induce an increase in heart rate of 20 bpm (∆HR 
20bpm). Values are mean ± SEM. 
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Discussion 
 
In this thesis we aimed to elucidate whether cardiac reserve, assessed by low-dose 
dobutamine stress echocardiography, can be used as a tool to evaluate and predict 
treatment effects, sub clinical heart disease and the influence of β1-adrenoceptor 
gene polymorphism.  
Investigation of cardiac function at rest cannot detect early and masked 
heart disease. The heart’s capacity to adjust to the demands placed upon it can be 
the first and only sign of heart dysfunction. Therefore investigations under stress 
can be used to show these first alterations in heart function.  
Heart failure is caused by diverse etiologies and is characterized by elevated 
levels of circulating catecholamines which affects the adrenoceptor-adenylyl 
cyclase – cascade in the heart. During the development of heart failure and 
hypertension there is an increased downregulation of the β1-adrenoceptor density, 
while other diseases, like diabetes, mainly influence below the receptor level, by 
altering the Gi:Gs-protein ratio. All these alterations in the cascade result in an 
impaired signalling function and to a markedly blunted β1-adrenoceptor-mediated 
contractile response.  
Dobutamine acts by increasing synthesis of cAMP and thereby foremost 
depends on the β1-adrenoceptor and the subsequent adenylyl cyclase – cascade. 
Function of this cascade mirrors the status of the heart. Low doses of dobutamine 
mainly increase the hearts contractility and dobutamine has some advantages 
compared with other drugs, like phosphodiesterase inhibitors i.e enoximone and 
milrinone that also affect the amount of cAMP in the myocytes. Clinically these 
drugs also mimic sympathetic stimulation and increase cardiac output but these 
drugs have the disadvantage of a long half-life, 2.5-10 hours, whereas dobutamine 
has a half-life of only 2 minutes. Furthermore, low doses of dobutamine rarely 
cause any undesirable side-effects and if any they are easily dissolved by stopping 
the infusion. 
The cardiac reserve can be studied with different methods. However, we 
chose to study the cardiac reserve using low-dose DSE, as it has been shown to be 
a good predictor of prognosis and outcome in patients with heart failure [Paelinck, 
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1999, Scrutinio, 2000]. Study I was a sub-study of a randomized, stratified, double-
blind, placebo-controlled trial in mild to moderate heart failure [Waagstein, 2003].  
Using radionuclide angiography Waagstein et al studied the cardiac reserve during 
steady state submaximal exercise. Treatment with metoprolol resulted in increased 
LVEF both at rest and during submaximal exercise, corresponding to what we 
reported studying the cardiac reserve with low-dose DSE, 7 units vs. 8 units 
compared to our 5 units vs. 9 units in ∆LVEF.  
Studying cardiac reserve with low-dose dobutamine using equilibrium 
radionuclide ventriculography can also be used in the same way as DSE to predict 
prognosis and outcome [Ramahi, 2001, Ramahi, 2001]. However, equilibrium 
radionuclide ventriculography is not a real-time examination, it requires average 
of the images over several minutes and the patient is exposed to nuclear radiation. 
Magnetic resonance imaging studies have shown to accurately determine segments 
with viability in the heart, in patients with ischemic cardiomyopathy [Baer, 1998, 
Bree, 2006]. Furthermore, low-dose dobutamine magnetic resonance imaging has 
shown to have higher sensitivity and specificity compared with echocardiography 
[Saito, 2000]. However, it is more time consuming, expensive and not as easily 
assessable when compared with echocardiography.  
There is poor consensus in the literature of what a low-dose dobutamine 
test is and to find an easy and elucidative test would be of great importance. 
Cardiac function at rest provides modest or no information to detect early and 
silent myocardial dysfunction. A healthy individual has a good resting function 
and cardiac reserve. As disease develops, resting function is usually maintained, 
whereas cardiac reserve declines. During further disease development resting 
function also decreases. We chose to investigate the cardiac reserve in humans not 
at fixed doses of dobutamine but rather at the same level of “heart stress”, ∆HR 
20 bpm (see Figure 13) in all subjects studied. There might be limitations in the 
method we chose to use for studying the cardiac reserve, for example to use 
chronotrophic response to study inotropic reserve assumes a parallel response to 
dobutamine both in the sinus node and in the myocyte, and this we cannot be 
certain of. However, to study the effect of low-dose dobutamine this way makes it 
possible to compare different types of patients and even compare the same patient 
before and after different therapies. So by using this unconventional low-dose 
stress test in patients with cardiomyopathy, we could show that these patients had 
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a cardiac reserve on beta-blocker treatment as well as before treatment. The 
cardiac reserve before beta-blocker treatment could also be used to discriminate 
between patients responding positively to treatment and patients not gaining any 
improvement in cardiac function with beta-blocker treatment. However, by using 
stress echocardiography we also observed that patients with poor response at 
baseline had a better cardiac reserve after metoprolol treatment.  
 
 
 
Figure 13. Cardiac reserve studied at ∆HR 20bpm during low-dose dobutamine infusion. 
Transplanted (n=20); Healthy controls (n=6); DCM, dilated cardiomyopathy patients with a 
good (n =8), moderat (n =7) and poor (n=7) response in global LVEF during long-term 
treatment with metoprolol.  
 
The world has greatly benefited from different animal models of disease. 
Experimental studies have been performed allowing complex systems and 
processes to be investigated. DSE is used for a better understanding of myocardial 
behavior during stress and to clarify the mechanisms involved. In experimental 
studies, where the individual differences are small and the animals are genetically 
very similar, we used fixed doses of dobutamine to study the cardiac reserve. In 
rats, DSE has mainly been used to study ischemia and remodeling after infarction 
[Cove, 1995, Fiordaliso, 2005, Iwanaga, 2004]. However, our studies show that the 
cardiac reserve is easily studied with DSE. By using this non-invasive method the 
disease development can be studied repeatedly in the same animal.  
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Our results (Study I) suggest that both global cardiac reserve and cardiac 
reserve in basal segments can be used to predict improvement in global LV 
function. However, cardiac reserve in the basal segments seems to be of greater 
importance when patients with chronic heart failure are evaluated for drug 
treatment. Absence or negative cardiac reserve in basal segments was associated 
with negative or poor chances of improvement. The cardiac reserve is affected by a 
number of different factors like the percentage of fibrosis, the degree of apoptosis 
or necrosis and presence of auto-antibodies against the β1-adrenoceptor in the 
heart. All these entities correlate with the prognosis of the patient and need to be 
further studied to determine if the cardiac reserve in the basal segments might be 
of importance for long-term outcome and survival. Well aware that this cohort 
(22 patients) is much too small to investigate long-term outcome, the ten-year 
survival in this cohort was significantly better in the patients with a good basal 
cardiac reserve compared with the patients that displayed a negative cardiac 
reserve in the basal segments of the heart, see Figure 14. I believe that low-dose 
dobutamine test has potential to be a good tool to find the patient group with the 
worst outcome. However, larger studies of cardiac reserve in the basal segments 
need to be performed. With improving echocardiography technology, for example 
with vector velocity imaging, the basal segments may be more easily accessible to 
study in the future. 
 
 
Figure 14. Ten-year survival rate in patients, divided in relation to cardiac reserve in the basal 
segments before treatment with metoprolol. Negative basal cardiac reserve (n=7), moderate 
basal cardiac reserve (n=8) and good basal cardiac reserve (n=7). 
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The study in patients with heart transplants (Study IV) showed that patients 
with grafts with the Gly49 polymorphism on the β1-adrenoceptor had lower heart 
rate, and better stress endurance and diastolic function compared with patients 
homozygous for Ser49. They also had a trend towards a better chronotropic 
reserve during the exercise test. Fast resting heart rate is associated with increased 
cardiovascular mortality [Kannel, 1987] so a  polymorphism that contributes to a 
lower resting heart rate may be especially beneficial for heart transplanted 
patients, since heart transplanted patients display an elevated resting heart rate 
and a reduced chronotrophic reserve compared with healthy controls [Mandak, 
1995]. Studying the cardiac reserve in the heart transplanted patients revealed a 
decrease in cardiac reserve at the lowest dose of dobutamine in patients with 
grafts with the Gly49 variants. This might reflect that this β1-adrenoceptor 
polymorphism has a greater responsiveness to circulating catecholamines. The 
results provide a possible explanation for differences in cardiac reserve among 
heart-transplanted patients. 
Our experimental studies (Studies II-III) showed that low-dose DSE is a 
robust and reliable tool to investigate cardiac function in small animal models. In 
the study on β1AR ECII immunized mice (Study III) we were able to demonstrate 
that early in the disease development no alterations were seen considering resting 
function and dimensions of the heart even though the cardiac reserve was 
decreased. Furthermore, with prolonged immunization the animals developed an 
excentric dilated cardiomyopathu. In study II on rats, we could show that the 
cardiac reserve decreases with age and is impaired in hypertension and diabetes, 
diseases known to affect heart function. In addition, we have unpublished data 
showing a downregulation of the β1-adrenoceptor density in the hypertensive rats 
which could be an explanation of the decreased cardiac reserve in these animals. 
However, the β1-adrenoceptor density was not altered in the diabetic rat and this 
is in accordance with what others have reported [Roth, D. A., 1995]. In 
streptozotocin-induced diabetic swine, Roth et al found a maintained β-
adrenoceptor density but an increase in the Gi:Gs-protein ratio which also leads 
to a decreased cAMP response to dobutamine stimulation.  
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Clinical implications 
The response of the LV to low-dose dobutamine infusion adds valuable clinical 
prognostic information. 
DSE has been shown to be an independent prognostic predictor of all-
cause mortality and hard cardiac events in elderly patients [Biagini, 2005]. 
Furthermore, low-dose DSE has been shown to be able to predict clinical 
outcome both in idiopathic dilated cardiomyopathy and ischemic patients 
[Rambaldi, 2005, Scrutinio, 2000]. Low-dose DSE, not commonly used in infarct 
studies, has recently been shown to predict LV dilatation and provide prognostic 
information in patients with acute myocardial infarction [Norager, 2005] and a 
positive DSE is associated with improved clinical outcome and prognosis in 
patients with acute myocardial infarction treated with coronary angioplasty 
[Tomaszuk-Kazberuk, 2005].  
Exercise electrocardiography is performed as a first-line non-invasive 
diagnostic stress test for evaluation of coronary artery disease. However, large 
numbers of patients referred for evaluation of chest pain are unable to perform 
adequate, exercise electrocardiographic testing. In these patients, DSE represents 
an exercise-independent stress alternative [Geleijnse, 1997]. Furthermore, 
considering the diagnostic problems of exercise electrocardiography and nuclear 
scintigraphy in women, DSE may be the stress test of choice because of its 
superior diagnostic specificity in women [Geleijnse, 2007].  
 
Conclusions 
We conclude that cardiac reserve can predict LV recovery in chronic heart failure 
patients during beta-blocker treatment and that β1-adrenoceptor polymorphism 
(Ser49Gly) affects the cardiac reserve in humans. Furthermore, cardiac reserve can 
be used to evaluate and predict subclinical and clinical heart disease in 
experimental studies. A decreased cardiac reserve could be the first sign of heart 
disease development.      
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I am still confused, but on a higher level. 
Enrico Fermi, Nobel Prize Laureate in Physics 1938 
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